Law 360

DECEMBER 15, 2022

a hemophilia-focused biopharm that Sanofi SA bought in 2018, has sued both companies in Delaware Chancery Court, alleging they have refused to pay his legal fees in an ongoing shareholder suit accusing him of insider trading ahead of the $11.6 A former board member of Bioverativ Inc., billion merger.

Legal 40

Legal Legal Court 40

JURIST

AUGUST 17, 2022

Though GSK is one of the primary sellers of Zantac, the drug has also been sold by Pfizer , Boehringer Ingelheim and Sanofi , among other companies. The FDA describes NDMA as a “probable human carcinogen,” which can cause cancer if consumed.

Manufacturing 104

Manufacturing Litigation Litigating Personal Injury 104

Law 360

JUNE 2, 2022

Denner and the activist hedge fund he controlled must face insider trading claims in a Delaware Chancery Court lawsuit alleging an unfair deal process behind the company's $11.6 billion sale to Sanofi in 2018.

Court 40

Court 40

Mondaq

DECEMBER 5, 2021

Well known life sciences company, Sanofi and it's Chinese brand name ‘赛诺菲' are highly regarded in the Chinese market.

40

40

SCOTUSBlog

MARCH 23, 2023

Sanofi , the justices will consider whether Amgen’s patent is too broad to be valid under federal patent rules. Amgen and other companies already have patents covering particular antibodies defined by their amino acid sequences. Sanofi claims that what Amgen did in this case was “claim a lot and disclose a little.”

Court 94

Court Statute Government Laws 94

Patently O

MAY 1, 2023

A skinny-label occurs when a generic drug company seeks approval for a drug with a label that omits the patented indications of the brand-name drug. Sanofi case, argued in March 2023. GlaxoSmithKline LLC , No. Polar Electro Oy , No. In addition, the Supreme Court has yet to rule on the Amgen v.

Court 80

Court Technology 80

FDA Law Blog

FEBRUARY 5, 2023

By Faraz Siddiqui — In the Spring of 2021, the Health Resources and Services Administration (HRSA) threatened six drug companies with billions of dollars in penalties for not providing 340B discounts to covered entities that sell drugs through vast networks of contract pharmacies (more background on earlier posts ).

Contract 52

Contract Statute Manufacturing Court 52

Patently O

APRIL 21, 2022

Sanofi, et al., Becton, Dickinson and Company , No. Scope and Procedure for the Enablement Requirement: Amgen Inc., 21-757 (CVSG requested April 18, 2022); Infringement and Damages: Do Enhanced Damages Require “Egregious Behavior” : Cisco Systems, Inc. SRI International, Inc. ,

Laws 82

Laws Court Construction Manufacturing 82

FDA Law Blog

OCTOBER 6, 2021

are diverting drugs purchased at low 340B prices to non-340B patients, the companies are declining to sell drugs to 340B covered entities that use multiple contract pharmacies. 12, 2021); Sanofi-Aventis U.S., Because of concerns that these contract pharmacies, which include some of the largest chains in the U.S., Becerra , No.

Manufacturing 52

Manufacturing Contract Statute Court 52

SCOTUSBlog

MAY 19, 2023

The justices ruled in favor of social media companies in Twitter, Inc. The chief finishes reading the letters and it is on to a (very) busy day of opinions. Justice Neil Gorsuch has the first opinion for a unanimous court in the patent case Amgen v. It is the first opinion from the March sitting. Federal Labor Relations Authority.

Law School 70

Law School Administrative Law Lawyer Lawyers 70

Patently O

APRIL 15, 2021

In this case, the employee started his own competing company and was sued for patent infringement. Kingston Technology Company, Inc., Furniture Company, Inc. Sanofi-Aventis U.S. The lower court barred an invalidity defense. 19-1459; Comcast Cable Communications, LLC v. Promptu Systems Corporation, et al. , Iancu , No.

Laws 82

Laws Court Technology Manufacturing 82

SCOTUSBlog

NOVEMBER 2, 2022

approximately $90 million in damages for Lanham Act violations by Abitron Austria GmbH and affiliated German and Austrian corporation defendants — including a sibling company named “Hetronic Germany GmBH,” which may give you some idea of the basis for the suit. Sanofi , 21-757. Before the U.S. Then comes Amgen v. Navajo Nation.

Government 103

Government Construction Court Statute 103

SCOTUSBlog

MAY 19, 2023

Share The Supreme Court on Thursday ruled against the drug company Amgen, which had sued Sanofi for infringing Amgen’s patent on antibodies that lower LDL cholesterol, sometimes called “bad” cholesterol. Amgen sued Sanofi for infringing these broader patents, which are known as “genus patents.”

Court Rules 114

Court Rules Court Manufacturing 114

Patently O

NOVEMBER 29, 2023

23-491 This case arises from multiple patent infringement lawsuits filed by Realtime Data LLC (d/b/a IXO) against various technology companies, including Fortinet, Inc., Sanofi, 142 S. Fortinet, No. Reduxio Systems, Inc., and others in the District of Delaware. 101 as claiming only abstract ideas and no inventive concept. 1713 (2022).

Court 73

Court Prima Facie Case Laws Technology 73

Patently O

FEBRUARY 24, 2022

Sanofi has the potential of being a huge case in terms of how it impacts the future of biotech innovation. .” And, rather than basing its argument on the 7th Amendment, Daikin’s petition is grounded in the Administrative Procedure Act and “the principles of separation of powers embedded within that Act.”

Laws 95

Laws Court Litigation Litigating 95

LegalReader

MARCH 5, 2021

Appeals court decision has far-reaching implications for drug patents.

Court Decisions 76

Court Decisions Court 76